Publication date: February 2017
Source:European Journal of Cancer, Volume 72, Supplement 1
Author(s): A. Necchi, J. Bellmunt, R. De Wit, D. Vaughn, Y. Fradet, J.L. Lee, L. Fong, N. Vogelzang, M. Climent, D. Petrylak, T. Choueiri, W. Gerritsen, H. Gurney, D. Quinn, S. Culine, C. Sternberg, Y. Mai, M. Puhlmann, R. Perini, D. Bajorin
http://ift.tt/2kKXxfo
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τρίτη 7 Φεβρουαρίου 2017
3LBA Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου